Promoting Adherence to Treatment in Schizophrenia
Promoting Adherence to Treatment in Schizophrenia
The project evaluates a culturally adapted, family-based intervention designed to promote
 treatment adherence among Mexican-Americans with schizophrenia using a randomized, controlled
 design in a public mental health setting. Mexican-American patients with schizophrenia and
 their families were randomly assigned to either: 1) one year of multi- family groups that
 emphasize the importance of attitudes towards adherence, subjective norms, and self-perceived
 and actual adherence skills in maintaining adherence, added to ongoing customary outpatient
 care; 2) standard multi-family groups without an emphasis on medication adherence, added to
 customary outpatient care; or 3) customary outpatient care only (monthly pharmacotherapy
 sessions and additional services as clinically needed). The study hypotheses are that
 subjects assigned to the adapted multi-family group would have better medication adherence,
 less psychiatric symptoms and fewer psychiatric hospitalizations throughout the course of the
 study (one year of treatment and one year of follow up) compared to the comparison
 conditions.
As above
Inclusion Criteria:

 -  DSM-IV diagnosis of schizophrenia or schizoaffective disorder;

 -  Between 18 and 50 years of age;

 -  Of Mexican origin and speaks Spanish fluently;

 -  Was without antipsychotic medication without medical authorization for one continuous
 week in the month prior to hospitalization;

 -  Was living with his/her family of origin immediately preceding the inpatient stay and
 would return to live with his/her family after discharge; and

 -  The patient and at least one family member were willing to participate.

 Exclusion Criteria:

 -  Patient on conservatorship or legal guardian status